China's Medical Imaging Equipment Market Hits ¥75B; Domestic DR/Ultrasound Expand in Africa & LatAm

China’s medical imaging equipment market reached approximately ¥75 billion in 2025, with CT systems accounting for 28% of the total. In Q1 2026, domestically manufactured digital radiography (DR) and portable ultrasound devices secured procurement contracts in 11 countries—including Kenya, Peru, and Nigeria—driven by CE/FDA/WHO PQ certifications and localized after-sales service networks. This development signals shifting dynamics for export-oriented medtech firms, supply chain partners, and procurement stakeholders active in emerging healthcare markets.

Event Overview

According to Qianzhan Network data released on May 8, 2026, China’s medical imaging equipment market size was about ¥75 billion in 2025. CT equipment represented 28% of that value. In Q1 2026, Chinese-made DR and portable ultrasound systems were awarded tenders in 11 countries across Africa and Latin America. These products hold CE, FDA, and WHO Prequalification (PQ) certifications, and are supported by local maintenance networks. Average delivery lead time was 45 days shorter than that of comparable Western-branded systems.

Industries Affected

Export-Oriented Medical Device Manufacturers

Manufacturers exporting DR and portable ultrasound systems face increased competitive pressure—and opportunity—in low- and middle-income country (LMIC) tenders. The certification alignment (CE/FDA/WHO PQ) and faster delivery timelines indicate a growing capability to meet international public procurement requirements, especially for primary care infrastructure projects.

Distribution & Tendering Service Providers

Firms facilitating tender participation—including regulatory compliance support, bid documentation preparation, and local partner coordination—are seeing rising demand. The successful bids in Kenya, Peru, and Nigeria suggest that localized service readiness—not just product specs—is now a decisive factor in LMIC procurement evaluations.

After-Sales Service & Spare Parts Logistics Providers

Local maintenance networks have become a documented differentiator. Companies managing field service, technician training, and spare parts warehousing in target markets may experience higher engagement from domestic OEMs seeking to replicate or scale this model.

Component Suppliers for DR and Portable Ultrasound Systems

Suppliers of key subsystems—such as flat-panel detectors, FPGA-based beamformers, or lithium-ion battery modules—may see order volume shifts aligned with export-focused production planning. However, no change in supplier concentration or technology sourcing has been reported.

What Enterprises and Practitioners Should Monitor and Act On

Track official tender frameworks and certification reciprocity updates

Several African and Latin American national procurement agencies are revising technical evaluation criteria to explicitly weight certification validity (e.g., WHO PQ acceptance) and local service capacity. Stakeholders should monitor tender guidelines issued by ministries of health in Kenya, Nigeria, Peru, and other recent award recipients.

Assess exposure to DR and portable ultrasound export channels

Companies involved in logistics, customs brokerage, or regulatory consulting should review their current client portfolios for DR/ultrasound OEMs targeting LMICs. Prioritizing support for CE/FDA/WHO PQ-aligned documentation workflows may improve responsiveness to upcoming RFP cycles.

Distinguish between policy intent and actual tender execution

While the 11-country tender success is confirmed, it reflects discrete project awards—not systemic market access expansion. Stakeholders should avoid overgeneralizing regional penetration; instead, verify whether follow-up tenders in the same countries have opened or been delayed.

Prepare for accelerated delivery commitments in future bids

The 45-day delivery advantage cited is tied to existing local warehousing and technician deployment. Firms supporting OEMs should audit current inventory buffers and cross-border shipment routing options for key components to assess feasibility of similar lead-time reductions in new markets.

Editorial Perspective / Industry Observation

Observably, this trend reflects an operational maturation—not just a pricing strategy—behind Chinese medical device exports. The convergence of triple certification (CE/FDA/WHO PQ) and localized service infrastructure suggests a shift from transactional sales toward long-term public-sector partnership models. Analysis shows that such progress is currently concentrated in DR and portable ultrasound segments; no evidence indicates parallel momentum in MRI, PET/CT, or high-end CT systems. From an industry perspective, this is best understood as an early-stage signal of capability building—not yet a broad-based market transformation. Continued monitoring is warranted, particularly for how WHO PQ listing timelines evolve and whether regional procurement consortia (e.g., PAHO, AU Health) begin referencing these tender outcomes in benchmarking reports.

In summary, the ¥75 billion 2025 market size underscores China’s domestic scale, while the Q1 2026 tender wins highlight an emerging export competency grounded in certification rigor and service localization. This is not yet indicative of structural global market share gains, but rather a measurable step in capability alignment with LMIC procurement priorities. It is more accurately interpreted as a validation of targeted operational readiness than a wholesale shift in competitive positioning.

Source: Qianzhan Network (data released May 8, 2026).
Noted for ongoing observation: Certification renewal timelines for WHO PQ listings, and publication status of tender award details in recipient countries’ official procurement portals.